CN115209889A - 含有银杏内酯和大麻素类化合物的药物组合物及其在医药上的应用 - Google Patents
含有银杏内酯和大麻素类化合物的药物组合物及其在医药上的应用 Download PDFInfo
- Publication number
- CN115209889A CN115209889A CN202180018643.7A CN202180018643A CN115209889A CN 115209889 A CN115209889 A CN 115209889A CN 202180018643 A CN202180018643 A CN 202180018643A CN 115209889 A CN115209889 A CN 115209889A
- Authority
- CN
- China
- Prior art keywords
- bilobalide
- pharmaceutical composition
- pharmaceutically acceptable
- stereoisomer
- metabolite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种含银杏内酯类化合物和大麻素类化合物的组合物及其在医药上的应用。
Description
PCT国内申请，说明书已公开。
Claims (21)
- PCT国内申请，权利要求书已公开。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2020101481998 | 2020-03-05 | ||
| CN202010148199 | 2020-03-05 | ||
| PCT/CN2021/079278 WO2021175311A1 (zh) | 2020-03-05 | 2021-03-05 | 含有银杏内酯和大麻素类化合物的药物组合物及其在医药上的应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115209889A true CN115209889A (zh) | 2022-10-18 |
Family
ID=77614407
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202180018643.7A Pending CN115209889A (zh) | 2020-03-05 | 2021-03-05 | 含有银杏内酯和大麻素类化合物的药物组合物及其在医药上的应用 |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN115209889A (zh) |
| WO (1) | WO2021175311A1 (zh) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114272237A (zh) * | 2022-01-21 | 2022-04-05 | 苏州大学附属第一医院 | 一种用于治疗骨性关节炎的银杏提取物 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019089583A1 (en) * | 2017-10-30 | 2019-05-09 | Endocanna Health, Inc. | Cannabinoid formulations |
| CN110636834A (zh) * | 2017-02-15 | 2019-12-31 | 分子浸剂有限公司 | 制剂 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106727744A (zh) * | 2016-12-28 | 2017-05-31 | 河南八灵电子科技有限公司 | 一种治疗心绞痛的药物 |
| CN110522747A (zh) * | 2018-05-24 | 2019-12-03 | 成都百裕制药股份有限公司 | 银杏萜内酯在制备预防或治疗动脉粥样硬化药物中的应用 |
-
2021
- 2021-03-05 CN CN202180018643.7A patent/CN115209889A/zh active Pending
- 2021-03-05 WO PCT/CN2021/079278 patent/WO2021175311A1/zh active Application Filing
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110636834A (zh) * | 2017-02-15 | 2019-12-31 | 分子浸剂有限公司 | 制剂 |
| WO2019089583A1 (en) * | 2017-10-30 | 2019-05-09 | Endocanna Health, Inc. | Cannabinoid formulations |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021175311A1 (zh) | 2021-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2573070B1 (en) | Crystal form of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparation method and use thereof | |
| CA2703971C (en) | Stabilized pediatric suspension of carisbamate | |
| HU224619B1 (hu) | Metformin és fibrát kombinációját tartalmazó gyógyászati készítmények és ezek alkalmazása kórosan magas vércukorszint csökkentését célzó gyógyszerek előállítására | |
| CN110944638A (zh) | 尼拉帕尼组合物 | |
| RU2494736C2 (ru) | Комбинация, включающая паклитаксел, для лечения рака яичников | |
| JP2022507533A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
| EP2575807B1 (en) | Formulation based on sulpiride and a synergistic homeopathic composition for treatment of depressive syndrome | |
| CN115209889A (zh) | 含有银杏内酯和大麻素类化合物的药物组合物及其在医药上的应用 | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| JPS61286326A (ja) | パ−キンソン病治療薬 | |
| CN106146558A (zh) | 新的噁唑烷酮类化合物及其制备方法 | |
| CN113368117A (zh) | 含有丙泊酚前药和别孕烯醇酮前药化合物的药物组合物及其在医药上的应用 | |
| CN101467967B (zh) | 用于静脉和脑内注射的两元溶液型制剂 | |
| CA2434526A1 (en) | Methods of administering epothilone analogs for the treatment of cancer | |
| CN113368084A (zh) | 含有大麻二酚，丙泊酚前药和别孕烯醇酮前药化合物的药物组合物及其在医药上的应用 | |
| IL300023A (en) | Low dose regimen and formulation of 5-methyl-1,2,4-oxadiazol-3-yl compound | |
| JPS63267781A (ja) | 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤 | |
| CN107582560B (zh) | 木通皂苷d的溶血栓作用及其应用 | |
| US11185517B2 (en) | Pharmaceutical composition for treatment or remission of chronic myelogenous leukemia | |
| RU2322236C2 (ru) | Лекарственное средство для лечения доброкачественных и злокачественных опухолевых заболеваний, содержащее производное дисоразола | |
| CN108503651B (zh) | 一种用于治疗脑卒中的螺环化合物 | |
| CN104840480B (zh) | 二甲双胍/叶酸/维生素b12药物组合物的新用途 | |
| WO2021185356A1 (zh) | 丁基苯酞及其衍生物的用途 | |
| US20200268761A1 (en) | Compositions comprising ibrutinib and an alkaloid having enhanced bioavailability | |
| JP2004538305A (ja) | ３−ヘテロシクリル−及び３−シクロアルキル−３−アリールオキシプロパンアミンによる慢性疼痛の治療 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |